A61K 2035/115
Probiotics
Official title: {Probiotics}
A61K2035/115 (Probiotics) appears on 800 US grants and 1,687 published applications in this corpus.
Search patents in A61K- Granted patents
- 800
- Published applications
- 1,687
- Assignees
- 798
- Inventors
- 3,118
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 2 |
| 2008 | 0 | 3 |
| 2009 | 0 | 0 |
| 2010 | 0 | 9 |
| 2011 | 1 | 13 |
| 2012 | 1 | 16 |
| 2013 | 4 | 19 |
| 2014 | 9 | 27 |
| 2015 | 14 | 72 |
| 2016 | 33 | 96 |
| 2017 | 46 | 83 |
| 2018 | 67 | 88 |
| 2019 | 45 | 149 |
| 2020 | 72 | 152 |
| 2021 | 99 | 156 |
| 2022 | 113 | 168 |
| 2023 | 73 | 143 |
| 2024 | 77 | 188 |
| 2025 | 76 | 171 |
| 2026 | 70 | 129 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Composition for preventing or treating inflammatory bowel disease6 Oct 2026US 12,751,979 B2Ajou University Industry-Academic Cooperation Foundation
- Oral and intestinal health products6 Oct 2026US 12,751,985 B2
- Probiotic Bacillus compositions and methods of use29 Sep 2026US 12,746,261 B2BiomEdit, Inc.
- Probiotics compositions and method of using the same to enhance growth and social function in children29 Sep 2026US 12,746,262 B2The General Hospital Corporation
- Probiotics compositions and method of using the same to enhance growth and social function in children29 Sep 2026US 12,746,264 B2The General Hospital Corporation
- Probiotic-fortified, high-protein food product and method of making same8 Oct 2026US 2026/0305659 A1
- Pharmaceutical combination for cancer treatment8 Oct 2026US 2026/0306466 A1Miyarisan Pharmaceutical Co., Ltd.
- Formulation of a probiotic stable at baking temperatures and encapsulation of the same to ensure its life on shelf foods until its viability in consumption8 Oct 2026US 2026/0306559 A1Grupo Bimbo S.A. B. DE C.V.
- Mixture of hmos and b. infantis8 Oct 2026US 2026/0306563 A1Societe des Produits Nestle S. A.
- Probiotic compositions and their use in the prevention and/or treatment of oral cavity pathologies and/or disorders8 Oct 2026US 2026/0306565 A1Synbalance Srl
Most cited
By later US patents
- Probiotic recolonisation therapy240US 8,460,648 B22013
- Probiotic compositions containing clostridiales for inhibiting inflammation118US 9,610,307 B2Evelop Biosciences, Inc. · 2017
- Probiotic recolonisation therapy117US 9,408,872 B2Crestovo LLC · 2016
- Bacterium for use as a probiotic for nutritional and medical applications104US 9,314,489 B24D Pharma Research Limited · 2016
- Compositions for probiotic recolonisation therapy76US 9,040,036 B22015